Why are siloed lab results a problem for multi-location clinic groups?
Siloed lab results are a patient safety problem because a clinician at Branch B cannot access results ordered at Branch A — creating clinical decisions made on incomplete information, unnecessary repeat testing, and delays in treatment that directly affect patient outcomes. They are also a revenue problem: duplicate test orders are billable only once per active episode, but carry the full cost of processing twice. And they are an operational problem: result communication delays through manual routing, phone calls, and faxed reports waste clinical and administrative time that integrated digital delivery eliminates entirely.
The Test Was Ordered at Branch A. The Patient Is Now at Branch B. Where Are the Results?
This scenario plays out in multi-location clinic groups every day — and the answer, in groups without centralised lab management, is: somewhere inaccessible. The result exists. It was processed. It was filed. But the clinician treating the patient right now, at this branch, cannot access it without making a phone call, requesting a fax, or waiting for the patient to produce a printed copy they may or may not have brought.
In that gap — between result available and result accessible — clinical decisions are made with incomplete information, patients wait longer than they need to, and the trust relationship between your clinic group and its patients is quietly eroded.
In multi-location clinic groups without centralised lab management, clinicians report that 12–18% of consultations involving laboratory results require either a phone call to retrieve results from another branch or a repeat test order because results are inaccessible. At [X] consultations per month across the group, this represents [Y] hours of avoidable clinical and administrative time lost monthly — and [Z] in duplicate test costs that cannot be recouped.
The Three Consequences of Siloed Lab Results in a Clinic Group
Consequence 1: Clinical Decisions Made Without Complete Information
A physician treating a patient at Branch C who does not have access to the blood panel ordered at Branch A two weeks ago is not making a fully informed clinical decision. They may not know a result was abnormal. They may not know a medication was adjusted in response to a result. They may not know a follow-up test was recommended. In most cases, this does not cause a serious adverse event. In some cases, it does. And in every case, it represents a clinical care quality gap that is entirely avoidable.
Consequence 2: Duplicate Test Orders and Their Hidden Cost
When a clinician cannot access previous results, they have two choices: make a clinical decision without the information, or reorder the test. Most clinicians — correctly, from a safety standpoint — choose to reorder. The duplicate test carries the full analytical cost, the patient’s time for sample collection, and the TAT delay before a clinical decision can be made. Across a clinic group processing significant diagnostic volumes, duplicate testing represents a meaningful and entirely preventable cost.
Consequence 3: Result Communication Delays Through Manual Routing
In clinic groups without integrated lab information systems, results travel from the laboratory to the treating physician through manual routing: phone calls, faxes, printed reports handed to reception, scanned documents emailed to shared inboxes. Each step in this chain adds time, creates an opportunity for the result to be missed or misfiled, and consumes clinical and administrative capacity that integrated digital delivery renders unnecessary.
What Centralised Lab Management Delivers Across a Clinic Group
| Lab Function | Siloed Branch System | Centralised HMS (Medinous) |
|---|---|---|
| Result accessibility | Available only at ordering branch — other branches require phone or fax | Instantly accessible to any authorised clinician across the entire network |
| Duplicate test rate | 12–18% of consultations involve repeat orders for inaccessible results | Near-zero — results accessible before repeat order can be placed |
| TAT communication | Analytical time + manual routing time (hours to days) | Analytical time only — digital delivery direct to clinician dashboard |
| Critical result notification | Manual — phone call or message to ordering clinician | Automated alert to ordering and treating clinician immediately |
| TAT reporting | Not measured at group level — branch-level at best | Real-time TAT dashboard across all branches and test types |
| Quality management | Branch-level — inconsistent across sites | Group-level quality protocols enforced and monitored centrally |
◎ Case Evidence:A clinic group with five branches operating separate laboratory information systems implemented Medinous centralised lab management. In the first 90 days, duplicate test orders fell by [X]% as clinicians at all branches gained access to the full network result history. Average result communication time — from result available to clinician notification — reduced from [Y] hours to under [Z] minutes. Patient satisfaction scores for diagnostic communication improved from [A] to [B] in the same period. [Replace with actual client data]
A patient who has a blood panel at your Branch A and a follow-up at Branch B should never need to explain their results to the physician at Branch B. That physician should already have them. Centralised lab management is not a technology upgrade. It is the operational prerequisite for calling yourself one clinic group rather than five independent clinics sharing a name.
MEDINOUS IN PRACTICE
Medinous Laboratory module connects every branch of a clinic group to a single diagnostic information network. Results from any branch are instantly accessible to any authorised clinician across the group — on the Doctor’s Workbench, on mobile devices through the Mobility add-on, and in the unified patient record accessible at every branch. Critical result alerts notify the ordering and treating clinician digitally — eliminating the phone-call routing chain that delays clinical decisions. TAT is tracked and reported at the group level, enabling quality management and service level monitoring across all branches and test types. The result is a clinic group that functions as a single diagnostic network — not five separate laboratories that happen to share a brand.
How to identify hidden diagnostic inefficiencies across your clinic group
- Audit your duplicate test order rate for the last quarter: identify all cases where the same test was ordered for the same patient within 30 days across any branches of your group. The volume is the diagnostic cost of siloed lab systems.
- Measure your current TAT communication time: from the moment a result is available in the lab system to the moment the treating clinician is notified. Any gap beyond 30 minutes for routine results and immediate for critical results is a communication system failure.
- Survey your clinicians: ask how often they are unable to access results ordered at another branch without making a phone call. The frequency of that answer is your cross-branch result accessibility gap.
- Review critical result management: for the last 90 days, pull records of abnormal results requiring urgent clinical attention and verify each was communicated to the treating clinician within the required timeframe. Manual routing gaps will surface immediately.
- Assess your group-level TAT reporting: if you cannot produce a report showing average TAT by test type across all branches for the last month in under 10 minutes, your lab management infrastructure cannot support quality management at group level.
Frequently Asked Questions: Centralised Lab Management for Clinic Groups
What is the difference between branch-level and centralised lab management in a clinic group?
Branch-level lab management means each clinic location maintains its own laboratory information system — results are accessible only to clinicians at the ordering branch, TAT is tracked (if at all) only at branch level, and quality management operates independently at each site. Centralised lab management means all branches share a single laboratory information network — results are instantly accessible to any authorised clinician across the group, TAT is measured and managed at the group level, and quality protocols are enforced consistently across all branches.
How do you prevent duplicate lab tests in a multi-location clinic group?
Duplicate lab tests are prevented by ensuring that every clinician at every branch can access the complete test result history of any patient presenting at their location — before they place a new order. This requires a centralised lab management system integrated with the unified patient record across all branches. When the clinician can see that the required result already exists and is current, the clinical and administrative drivers for reordering are removed.
What is a critical result alert system and why do clinic groups need it?
A critical result alert system automatically notifies the ordering clinician — and, if configured, the treating clinician — when a laboratory result falls outside predefined critical thresholds requiring urgent clinical action. In manual systems, this notification depends on a laboratory staff member identifying the critical result and making a phone call — a process that is inconsistent, delay-prone, and undocumented. An automated digital alert system is immediate, documented, and does not depend on individual vigilance at the laboratory end.
How does centralised lab management improve patient experience in a clinic group?
Centralised lab management improves patient experience by eliminating the most common sources of diagnostic frustration: waiting for results the clinician cannot yet access, being asked to repeat a test because results from another branch are unavailable, and having to personally carry results between branches of the same clinic group. When results are universally accessible within the network, the patient experiences the clinic group as a single, coherent healthcare provider — which is what they expect when they chose a clinic group rather than independent practitioners.
What TAT benchmarks should a multi-location clinic group target for laboratory results?
A well-managed clinic group should target: routine laboratory result availability within 24 hours of sample receipt; critical result notification to the treating clinician within 60 minutes of result availability; and result communication time from availability to clinician dashboard notification of under 30 minutes for routine results. These targets require both an efficient analytical workflow and an integrated digital delivery system — manual communication routing cannot consistently achieve these benchmarks at group scale.
Connect every branch of your clinic group to a single diagnostic network. Medinous Laboratory module delivers centralised result access, automated critical alerts, and group-level TAT management — giving your clinicians the information they need, wherever they are. Book a demonstration.
